Protocol Editor

The Protocol Editor is the editorial identity for all Learn content on My Pep Calc. This page explains what that means, how articles are produced, and what we disclose.

What the Protocol Editor is

The Protocol Editor is a disclosed composite identity — not a single person, and not a fictional MD. It represents the founding team's research process: reading peer-reviewed literature, synthesizing community experience from peptide and GLP-1 forums, cross-checking with licensed compounding pharmacists, and translating all of that into plain, accurate, compliance-safe content.

We chose this model because it's honest. Many health content sites invent credentials or hide behind anonymous bylines. We'd rather be transparent about our process and let you evaluate it directly.

Editorial standards

Every article on My Pep Calc Learn follows these standards:

• Answer first. The top of every article answers the primary question directly. No burying the lede under five paragraphs of preamble.
• Claims require sources. Mechanistic claims, dosing ranges, and half-life data are cited to peer-reviewed literature or FDA/pharmacopeial references. Sources are listed at the bottom of every article.
• No medical advice. Every article is informational. We describe how protocols work, not what you should do. "Consult your prescribing provider" is not a legal disclaimer — it's the actual correct answer for dosing decisions.
• Regulatory accuracy. We report FDA status accurately — approved, compounded, investigational, research chemical. We do not sanitize or inflate regulatory standing.
• Calculator-grounded. Where possible, articles embed the actual reconstitution calculator or half-life chart so you can verify the math yourself, not just trust a number we printed.

Review process

Each article goes through this process before publishing:

1. Source audit. Primary sources identified and archived. PubMed IDs noted for clinical claims.
2. Draft against sources. Article written with every claim traceable to a cited source.
3. Compliance pass. All medical claims removed or reframed as informational. FDA status verified against current regulatory guidance.
4. Math check. Any formula or calculation verified against the actual calculator implementation in the app.
5. Date stamp. Published date and last-modified date are accurate. Articles are updated when evidence or regulatory status changes.

What we are adding

We intend to add a licensed medical reviewer — a prescribing physician or clinical pharmacist with direct experience in peptide and GLP-1 protocols — by Q3 2026. When that happens, this page will be updated with their credentials, disclosure of any conflicts of interest, and their specific scope of review.

We are telling you this now so you understand the current limitation and can factor it into how you use the content.

Scope of topics we cover

Protocol Editor articles cover:

• Peptide reconstitution (BPC-157, CJC-1295, Ipamorelin, TB-500, etc.)
• GLP-1 agonist protocols (Tirzepatide, Semaglutide compounded forms)
• Injection site rotation and technique
• Half-life pharmacokinetics and dosing frequency
• Multi-compound stack tracking and error reduction
• Compounding pharmacy regulations and legal status by compound

We do not cover: diagnosis, treatment of specific conditions, or recommendations for individuals. That's your provider's job.

Corrections and updates

If you find an error — factual, mathematical, or regulatory — email hello@mypepcalc.com with the article URL, the specific claim, and your source. We read every correction and update articles when we are wrong.